Literature DB >> 10539118

Using healthcare claims data for outcomes research and pharmacoeconomic analyses.

H G Birnbaum1, P Y Cremieux, P E Greenberg, J LeLorier, J A Ostrander, L Venditti.   

Abstract

Healthcare claims data are a practical complement to data from randomised controlled trials (RCTs) for evaluating health outcomes in non-experimental settings and for generalising results to a broader population. Claims data are a relatively inexpensive way to obtain useful information about patient demographics, as well as healthcare resources used for specific medical conditions and procedures from large numbers of patients over extended periods of time. With claims data, it is possible to identify patients who meet specific medical or sociodemographic criteria, estimate their costs, define episodes of medical care, and measure outcomes more globally than is possible with RCT data. Statistical methods exist to address some of the inherent issues with claims data due to their limited clinical detail. We also identify extensions of claims data to productivity issues, the use of centralised claims data such as in Canada, and the application of new statistical methods to outcomes research literature such as sample selection correction methods.

Entities:  

Mesh:

Year:  1999        PMID: 10539118     DOI: 10.2165/00019053-199916010-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  32 in total

1.  The application of sample selection models to outcomes research: the case of evaluating the effects of antidepressant therapy on resource utilization.

Authors:  W H Crown; R L Obenchain; L Englehart; T Lair; D P Buesching; T Croghan
Journal:  Stat Med       Date:  1998-09-15       Impact factor: 2.373

Review 2.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

Authors:  M C Weinstein; J E Siegel; M R Gold; M S Kamlet; L B Russell
Journal:  JAMA       Date:  1996-10-16       Impact factor: 56.272

3.  Inhaled corticosteroids and the prevention of readmission to hospital for asthma.

Authors:  L Blais; P Ernst; J F Boivin; S Suissa
Journal:  Am J Respir Crit Care Med       Date:  1998-07       Impact factor: 21.405

4.  The Home Infusion Therapy/Relative Benefit Index: summary of an analysis using insurance claims data.

Authors:  H G Birnbaum; M Tang
Journal:  Med Care       Date:  1998-05       Impact factor: 2.983

Review 5.  The use of claims databases for outcomes research: rationale, challenges, and strategies.

Authors:  B R Motheral; K A Fairman
Journal:  Clin Ther       Date:  1997 Mar-Apr       Impact factor: 3.393

Review 6.  Pharmacoeconomics: state of the art in 1997.

Authors:  K A Schulman; B P Linas
Journal:  Annu Rev Public Health       Date:  1997       Impact factor: 21.981

7.  Impact of pharmaceutical underutilization: a study of insurance drug claims data.

Authors:  B S Harrow; B L Strom; J A Gans
Journal:  J Am Pharm Assoc (Wash)       Date:  1997 Sep-Oct

8.  Analysis of coronary angioplasty practice in the United States with an insurance-claims data base.

Authors:  E J Topol; S G Ellis; D M Cosgrove; E R Bates; D W Muller; N J Schork; M A Schork; F D Loop
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

9.  Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.

Authors:  G F Riley; A L Potosky; J D Lubitz; L G Kessler
Journal:  Med Care       Date:  1995-08       Impact factor: 2.983

10.  A review of the first year of Medicare coverage of erythropoietin.

Authors:  R I Griffiths; N R Powe; J Greer; G de Lissovoy; G F Anderson; P K Whelton; A J Watson; P W Eggers
Journal:  Health Care Financ Rev       Date:  1994
View more
  33 in total

Review 1.  Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

Authors:  K A Payne; S Esmonde-White
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

Review 2.  Methods for claims-based pharmacoeconomic studies in psychosis.

Authors:  Frank Gianfrancesco; Ruey-Hua Wang; Ramy Mahmoud; Richard White
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  Retrospective economic and outcomes analyses using non-US databases: a review.

Authors:  Lizheng Shi; Eric Q Wu; Meredith Hodges; Andrew Yu; Howard Birnbaum
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data.

Authors:  Jean Lachaine; Robert J Petrella; Elizabeth Merikle; Farzad Ali
Journal:  Can J Cardiol       Date:  2008-04       Impact factor: 5.223

5.  Characterizing medical care by disease phase in metastatic colorectal cancer.

Authors:  Xue Song; Zhongyun Zhao; Beth Barber; Christopher Gregory; David Schutt; Sue Gao
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

6.  Combining the Power of Artificial Intelligence with the Richness of Healthcare Claims Data: Opportunities and Challenges.

Authors:  David Thesmar; David Sraer; Lisa Pinheiro; Nick Dadson; Razvan Veliche; Paul Greenberg
Journal:  Pharmacoeconomics       Date:  2019-06       Impact factor: 4.981

7.  Analysis of the costs and consequences of adherence to therapy in hip fracture patients. Results of a longitudinal analysis of.

Authors:  Umberto Tarantino; Sergio Ortolani; Luca Degli Esposti; Chiara Veronesi; Stefano Buda; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

8.  Characteristics of patients initiating teriparatide for the treatment of osteoporosis.

Authors:  S A Foster; K A Foley; E S Meadows; J A Johnston; S Wang; G M Pohl; S R Long
Journal:  Osteoporos Int       Date:  2007-08-21       Impact factor: 4.507

9.  Veridical Causal Inference using Propensity Score Methods for Comparative Effectiveness Research with Medical Claims.

Authors:  Ryan D Ross; Xu Shi; Megan E V Caram; Pheobe A Tsao; Paul Lin; Amy Bohnert; Min Zhang; Bhramar Mukherjee
Journal:  Health Serv Outcomes Res Methodol       Date:  2020-10-20

10.  Cost of stress urinary incontinence: a claims data analysis.

Authors:  Howard G Birnbaum; Stephanie A Leong; Emily F Oster; Kraig Kinchen; Peter Sun
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.